Literature DB >> 29067593

JSH guideline for tumors of hematopoietic and lymphoid tissues-leukemia: 3. Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL).

Jin Takeuchi1, Shigeru Kusumoto2, Hideki Akiyama3, Yoshinobu Kanda4, Koji Izutsu5.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29067593     DOI： 10.1007/s12185-017-2350-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  3 in total

1.  10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation.

Authors:  Katsumichi Fujimaki; Yukako Hattori; Hideaki Nakajima
Journal:  Int J Hematol       Date:  2017-11-29       Impact factor: 2.490

2.  Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia.

Authors:  Hidefumi Hiramatsu; Souichi Adachi; Katsutsugu Umeda; Itaru Kato; Lamis Eldjerou; Andrea Chassot Agostinho; Kazuto Natsume; Kota Tokushige; Yoko Watanabe; Stephan A Grupp
Journal:  Int J Hematol       Date:  2019-11-11       Impact factor: 2.490

3.  Characteristics of methotrexate-induced stroke-like neurotoxicity.

Authors:  Kentaro Watanabe; Yuki Arakawa; Eiji Oguma; Taichi Uehara; Masato Yanagi; Chigusa Oyama; Yuhachi Ikeda; Koji Sasaki; Kiyotaka Isobe; Makiko Mori; Ryoji Hanada; Katsuyoshi Koh
Journal:  Int J Hematol       Date:  2018-09-04       Impact factor: 2.490
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.